// App-Quantinova.ai

AB0295 : CHANGE IN DISEASE ACTIVITY AND TREATMENT RESPONSE AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK

Researchers

Presenter

  • S. Henning

Principal Investigators

  • L. Groves

  • M. Hurst

  • D. Sugrue

  • J. Gordon

  • E. Choy

Medical Centers

  • Bristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, United Kingdom

  • (HEOR) Ltd, Health Economics and Outcomes Research, Cardiff, United Kingdom

  • CREATE Centre, Section of Rheumatology, Institute of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved